Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products like plasma, blood derivatives, and vaccines. Beyond product supply, Cencora offers comprehensive support services, such as pharmacy management, staffing solutions, and strategic consulting. It develops and implements supply management software, provides packaging services for both institutional and retail healthcare settings, and assists with clinical trial support, post-market approval processes, and commercialization strategies. For biotechnology and pharmaceutical manufacturers, the company delivers data analytics, outcomes research, and other specialized services. Furthermore, Cencora serves the animal health market, providing pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients for both companion and production animals. It also offers sales force support to manufacturers and specialized services to medical professionals, particularly oncologists, as well as to hospitals and dialysis clinics. The International Healthcare Solutions division concentrates on global pharmaceutical wholesale activities, associated services, and worldwide commercialization support. It ensures the efficient distribution of medicines, various healthcare goods, and related services to an international customer base comprising pharmacies, doctors, health centers, and hospitals. This segment also delivers specialized transportation and logistics solutions specifically designed for the biopharmaceutical sector. Founded in 1871, the company was formerly known as AmerisourceBergen Corporation before adopting the name Cencora, Inc. in August 2023. Its corporate headquarters are situated in Conshohocken, Pennsylvania.
前收盤價
US$323.85
+US$2.50 · +0.78%
盤中時間採用ET。市場資料可能有所延遲。
Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products like plasma, blood derivatives, and vaccines. Beyond product supply, Cencora offers comprehensive support services, such as pharmacy management, staffing solutions, and strategic consulting. It develops and implements supply management software, provides packaging services for both institutional and retail healthcare settings, and assists with clinical trial support, post-market approval processes, and commercialization strategies. For biotechnology and pharmaceutical manufacturers, the company delivers data analytics, outcomes research, and other specialized services. Furthermore, Cencora serves the animal health market, providing pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients for both companion and production animals. It also offers sales force support to manufacturers and specialized services to medical professionals, particularly oncologists, as well as to hospitals and dialysis clinics. The International Healthcare Solutions division concentrates on global pharmaceutical wholesale activities, associated services, and worldwide commercialization support. It ensures the efficient distribution of medicines, various healthcare goods, and related services to an international customer base comprising pharmacies, doctors, health centers, and hospitals. This segment also delivers specialized transportation and logistics solutions specifically designed for the biopharmaceutical sector. Founded in 1871, the company was formerly known as AmerisourceBergen Corporation before adopting the name Cencora, Inc. in August 2023. Its corporate headquarters are situated in Conshohocken, Pennsylvania.
日內區間
目前US$323.85
52週區間
目前US$323.85
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目(USD) | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 3213.33億 USD | 2939.59億 USD | 2621.73億 USD | 2385.87億 USD | 2139.89億 USD |
| 銷貨成本 | 3111.91億 USD | 2852.57億 USD | 2544.17億 USD | 2309.86億 USD | 2077.2億 USD |
| 毛利 | 101.42億 USD | 87.01億 USD | 77.56億 USD | 76.01億 USD | 62.69億 USD |
| 銷售、一般及管理費用 | 64.94億 USD | 56.61億 USD | 53.1億 USD | 48.49億 USD | 35.94億 USD |
| 營業費用 | 64.94億 USD | 56.61億 USD | 53.1億 USD | 48.49億 USD | 35.94億 USD |
| 利息收入 | 1.28億 USD | 9169.1萬 USD | 4671.9萬 USD | 2130.9萬 USD | 847萬 USD |
| 利息支出 | 4.2億 USD | 2.49億 USD | 2.76億 USD | 2.32億 USD | 1.83億 USD |
| 折舊和攤銷 | 10.68億 USD | 11.19億 USD | 9.81億 USD | 7.1億 USD | 5.15億 USD |
| 營業利益 | 36.48億 USD | 30.4億 USD | 24.47億 USD | 27.52億 USD | 26.75億 USD |
| 淨利 | 15.54億 USD | 15.09億 USD | 17.45億 USD | 16.99億 USD | 15.4億 USD |
公司資料更新於 2026年10月11日。
近期已公布業績
近期已公布業績
第三方分析師預期可能變動,並非 GoAI 建議。
平均目標
US$358.14
上漲空間 10.59%年度分割調整後的每股現金分配。
US$2.25
2025年(完整年度)-47.9% 自從 2021
2026年(部分年度):US$1.80
US$4.32
2,021
US$1.865
2,022
US$1.965
2,023
US$2.08
2,024
US$2.25
2,025
US$1.80
2,026*
* 在現有股息歷史記錄中,該日曆年僅包含部分期間。
| 行動 | 除息日 | 詳情 | 記錄日期 | 付款日期 |
|---|---|---|---|---|
股息 | 2026年8月14日 | US$0.60Quarterly | 2026年8月14日 | 2026年8月31日 |
股息 | 2026年5月15日 | US$0.60Quarterly | 2026年5月15日 | 2026年6月1日 |
股息 | 2026年2月13日 | US$0.60Quarterly | 2026年2月13日 | 2026年3月2日 |
股息 | 2025年11月14日 | US$0.60Quarterly | 2025年11月14日 | 2025年12月1日 |
股息 | 2025年8月15日 | US$0.55Quarterly | 2025年8月15日 | 2025年9月3日 |
股息 | 2025年5月16日 | US$0.55Quarterly | 2025年5月16日 | 2025年6月2日 |
除息 2026年8月14日
US$0.60
Quarterly
2026年8月14日登記 · 支付日 2026年8月31日
除息 2026年5月15日
US$0.60
Quarterly
2026年5月15日登記 · 支付日 2026年6月1日
除息 2026年2月13日
US$0.60
Quarterly
2026年2月13日登記 · 支付日 2026年3月2日
除息 2025年11月14日
US$0.60
Quarterly
2025年11月14日登記 · 支付日 2025年12月1日
除息 2025年8月15日
US$0.55
Quarterly
2025年8月15日登記 · 支付日 2025年9月3日
除息 2025年5月16日
US$0.55
Quarterly
2025年5月16日登記 · 支付日 2025年6月2日
報告持有此股票曝險的交易所交易基金。
State Street SPDR S&P 500 ETF1557.T1184.84億0.09%129.35兆 JPY0.09%¥122,850+0.12%
Vanguard Morningstar Total Stock Market ETFVTI19.01億0.08%2.3兆 USD0.03%US$381.94+0.63%
Vanguard S&P 500 ETFVOO16.73億0.10%1.8兆 USD0.03%US$715.59+0.61%
Vanguard Morningstar Mid-Cap ETFVO12.94億0.57%2264億 USD0.03%US$81.14+0.92%
iShares Core S&P 500 ETFIVV8.15億0.09%8964.4億 USD0.03%US$781.97+0.60%
State Street SPDR S&P 500 ETFSPY7.49億0.09%8172億 USD0.09%US$778.57+0.60%
Vanguard Morningstar Value ETFVTV5.71億0.22%2624億 USD0.03%US$220.59+0.44%
State Street Health Care Select Sector SPDR ETFXLV4.37億1.00%435.37億 USD0.08%US$170.81+1.58%
State Street SPDR S&P 500 ETF1557.T
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard S&P 500 ETFVOO
Vanguard Morningstar Mid-Cap ETFVO
iShares Core S&P 500 ETFIVV
State Street SPDR S&P 500 ETFSPY
Vanguard Morningstar Value ETFVTV
State Street Health Care Select Sector SPDR ETFXLVAI 生成內容及延遲市場資料僅供資訊與教育用途,不構成投資建議。